# General Hospital of Ningxia Medical University

Organization · id `cardio:org-general-hospital-of-ningxia-medical-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=General+Hospital+of+Ningxia+Medical+University>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 5 trials in this atlas.

## Technical summary

Sponsor class other. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: General Hospital of Ningxia Medical University
- Sponsor class: OTHER

## Connected pages

- Sponsors: Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis (`cardio:ct-nct03342807`)
- Sponsors: HELIOS China Registry: Evaluation of the HELIOS Stent in a Real-World Patient Population (`cardio:ct-nct03916432`)
- Sponsors: Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology (`cardio:ct-nct03917563`)
- Sponsors: Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions (`cardio:ct-nct07145463`)
- Sponsors: 3-Dimensional Simulation Guided Transcatheter Aortic Valve Replacement in Aortic Regurgitation(DIGITAL) (`cardio:ct-nct07398911`)

## Provenance

Content hash: 2153fc18ecbd65080cdd43a97da1fc2d9efb2a3633694f422c1d2a516fd181f7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
